# Dyne Therapeutics, Inc. (DYN) - Q2 2026 earnings

Reported July 30, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-1.08 | $-0.75 |

Earnings filing reader: [8-K 0001193125-26-323940](https://www.opencapital.sh/filings/0001193125-26-323940)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-323940.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1818794/000119312526323940/0001193125-26-323940-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1818794/000119312526323639/0001193125-26-323639-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/dyn/earnings/q2-2026